Item Type | Name |
Academic Article
|
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
|
Academic Article
|
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
|
Academic Article
|
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
|
Academic Article
|
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.
|
Academic Article
|
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies.
|
Academic Article
|
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
|
Academic Article
|
Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial.
|
Academic Article
|
Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
|
Academic Article
|
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).
|
Academic Article
|
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.
|
Academic Article
|
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
|
Academic Article
|
Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial.
|
Academic Article
|
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
|
Academic Article
|
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
|
Academic Article
|
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
|
Academic Article
|
Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.
|
Academic Article
|
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.
|
Academic Article
|
Insights into the role of progesterone receptors in breast cancer.
|
Academic Article
|
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
|
Academic Article
|
Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.
|
Academic Article
|
Molecular profiles of progesterone receptor loss in human breast tumors.
|
Concept
|
Receptors, Progesterone
|
Concept
|
Progesterone
|
Academic Article
|
A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative.
|
Academic Article
|
In vitro model systems for the study of hormone-dependent human breast cancer.
|
Academic Article
|
Current use of steroid hormone receptor assays in the treatment of breast cancer.
|
Academic Article
|
Therapy for cancer of the breast. Current status of steroid hormone receptors.
|
Academic Article
|
The use of stero?d hormone receptors in the treatment of human breast cancer: a review.
|
Academic Article
|
Hormone receptors in primary and advanced breast cancer.
|
Academic Article
|
The value of estrogen and progesterone receptors in the treatment of breast cancer.
|
Academic Article
|
Steroid hormone receptors in the management of human breast cancer.
|
Academic Article
|
Steroid hormone receptors and carcinoma of the breast.
|
Academic Article
|
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
|
Academic Article
|
Hormone receptors in the management of breast cancer.
|
Academic Article
|
Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
|
Academic Article
|
Heterogeneity in hormone receptor status in primary and metastatic breast cancer.
|
Academic Article
|
Biological differences among MCF-7 human breast cancer cell lines from different laboratories.
|
Academic Article
|
Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy.
|
Academic Article
|
Therapy in premenopausal women with advanced, oestrogen positive or/and progesterone positive breast cancer: surgical oophorectomy versus the LHRH analogue, Zoladex.
|
Academic Article
|
Megestrol acetate in breast cancer--a panel discussion.
|
Academic Article
|
Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.
|
Academic Article
|
Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.
|
Academic Article
|
bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.
|
Academic Article
|
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
|
Academic Article
|
Cytological evaluation of biological prognostic markers from primary breast carcinomas.
|
Academic Article
|
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.
|
Academic Article
|
Steroid hormone receptors in breast cancer management.
|
Academic Article
|
Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.
|
Academic Article
|
Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.
|